Your browser doesn't support javascript.
Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola.
Sebastião, Cruz S; Galangue, Manuela; Gaston, Celestina; Van-Dunen, Rui; Quivinja, Joltim; Lunbungululo, Emiliana; Alfredo, Domingos; Sozinho, Alberto; Teixeira, Alice; Manico, Eunice; Machado, Deodete; Mateus, António; David, Zinga; Paixão, Joana; Neto, Zoraima; de Vasconcelos, Jocelyne Neto; Morais, Joana.
  • Sebastião CS; Instituto Nacional de Investigação em Saúde (INIS), Luanda, Angola.
  • Galangue M; Centro de Investigação em Saúde de Angola (CISA), Caxito, Angola.
  • Gaston C; Instituto Superior de Ciências da Saúde (ISCISA), Universidade Agostinho Neto (UAN), Luanda, Angola.
  • Van-Dunen R; Instituto Nacional de Investigação em Saúde (INIS), Luanda, Angola.
  • Quivinja J; Instituto Nacional de Investigação em Saúde (INIS), Luanda, Angola.
  • Lunbungululo E; Instituto Nacional de Investigação em Saúde (INIS), Luanda, Angola.
  • Alfredo D; Instituto Nacional de Investigação em Saúde (INIS), Luanda, Angola.
  • Sozinho A; Instituto Nacional de Sangue, Ministry of Health, Luanda, Angola.
  • Teixeira A; Clínica Girassol, Ministry of Health, Luanda, Angola.
  • Manico E; Instituto Nacional de Sangue, Ministry of Health, Luanda, Angola.
  • Machado D; Clínica Girassol, Ministry of Health, Luanda, Angola.
  • Mateus A; Instituto Nacional de Sangue, Ministry of Health, Luanda, Angola.
  • David Z; Instituto Nacional de Sangue, Ministry of Health, Luanda, Angola.
  • Paixão J; Instituto Nacional de Investigação em Saúde (INIS), Luanda, Angola.
  • Neto Z; Instituto Nacional de Investigação em Saúde (INIS), Luanda, Angola.
  • de Vasconcelos JN; Instituto Nacional de Investigação em Saúde (INIS), Luanda, Angola.
  • Morais J; Instituto Nacional de Investigação em Saúde (INIS), Luanda, Angola.
BMC Infect Dis ; 21(1): 1131, 2021 Nov 02.
Article in English | MEDLINE | ID: covidwho-1501990
ABSTRACT

BACKGROUND:

SARS-CoV-2 emerged in China and spread throughout the world due to its rapid transmission. The exposure rate in the healthy population is unknown, mainly in resource-limited countries. Herein, we estimated the seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among blood donors in Luanda, the capital city of Angola.

METHODS:

This was a retrospective study conducted with 343 blood donors. Chi-square and logistic regression were calculated to predict the independent variable for SARS-CoV-2 infection and deemed significant when p < 0.05.

RESULTS:

Seroprevalence of anti-SARS-CoV-2 was 4.7%. Positivity rates varied to age groups (3.5-14.3%), gender (0-5%), area of residence (3.1-.6%), educational level (5.1-10.2%), occupation (4.4-7.7%), and the blood donor category (2.0-5.1%). Past and recent infections were detected in 3.2% and 1.5%, respectively. Blood donors under the age of 20 years (OR 4.58, p = 0.241) and from non-urbanized areas (OR 1.86, p = 0.293) presented a high risk related to infection. The infection was higher in blood group A and lower in blood group O. The risk of SARS-CoV-2 infection has increased from January 2020 (OR 0.03, p = 0.001) to August 2020 (OR 0.57, p = 0.426).

CONCLUSIONS:

We provide an estimate of the exposure of healthy blood donors in Luanda. Also, we detected anti-SARS-CoV-2 in January 2020, indicating that the SARS-CoV-2 could have been imported during the first month of 2020. Further studies should be performed to assess the exposure rate in different groups from Angola.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Donors / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Humans / Young adult Country/Region as subject: Africa Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S12879-021-06814-0

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Donors / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Humans / Young adult Country/Region as subject: Africa Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S12879-021-06814-0